Tag: autism

Autism Spectrum Disorder and ADHD with The Low Dose Naltrexone

Autism Spectrum Disorder and ADHD with The Low Dose Naltrexone

Endorphins and Autism

Some researchers have suggested that excessive opioid activity in autistic children causes them to engage in repetitive “self-stimulatory” and self-injurious behaviours to further stimulate the pain-induced release of endogenous opiates. This hypothesis resulted in many trials using the opioid antagonist naltrexone. The action of naltrexone is to block opioid receptors thus creating a rebound effect of increased endorphin release, which in turn modulates the immune response, reducing cytokines and so reducing inflammation.3

In several of these trials naltrexone helped to increase socialisation, eye contact, pain sensitivity and a decrease in self-injurious/stimulatory behaviours. Endorphins are not the only neurotransmitters thought to be involved in autism, serotonin and dopamine are also found in abnormal concentrations which are likely to contribute to the condition.4

The use of Low Dose Naltrexone for children with autism spectrum disorders was studied in the 1990’s with researchers using from 5 mg to 50 mg daily. Many researchers noted better results with lower doses.

While not presenting the ultimate answer in the treatment of autism, naltrexone is shown to help alleviate some of the symptoms modulated by endogenous opioids.

https://ldnresearchtrust.org/autism-spectrum-disorder-and-promising-treatment-low-dose-naltrexone-paula-johnson

ADHD and Low Dose Naltrexone (LDN)

How about ADHD in an adult, and at what doses? Absolutely! I mean if it works in children, we might not use it in adults. We would still use typical dosing that we would use for pretty much anything else. You could start anywhere from 0.5 to 1.5, slowly increase the dose, and then top out at the maximum of 4.5 once a day. Not everybody gets to 4.5, and again that’s where working very closely with your medical professionals is going to help you find your happy dose.

https://ldnresearchtrust.org/adhd-and-low-dose-naltrexone-ldn

Autism spectrum disorder, mTOR and AMPK

Autism spectrum disorder, mTOR and AMPK

“Autism spectrum disorder (ASD) has a strong and complex genetic component with an estimate of more than 1000 genes implicated cataloged in SFARI (Simon0 s Foundation Autism Research Initiative) gene database. A significant part of both syndromic and idiopathic autism cases can be attributed to disorders caused by the mechanistic target of rapamycin (mTOR)-dependent translation deregulation. We conducted gene-set analyses and revealed that 606 out of 1053 genes (58%) included in the SFARI Gene database and 179 out of 281 genes (64%) included in the first three categories of the database (“high confidence”, “strong candidate”, and “suggestive evidence”) could be attributed to one of the four groups: 1. FMRP (fragile X mental retardation protein) target genes, 2. mTOR signaling network genes, 3. mTOR-modulated genes, 4. vitamin D3 sensitive genes. The additional gene network analysis revealed 43 new genes and 127 new interactions, so in the whole 222 out of 281 (79%) high scored genes from SFARI Gene database were connected with mTOR signaling activity and/or dependent on vitamin D3 availability directly or indirectly. We hypothesized that genetic and/or environment mTOR hyperactivation, including provocation by vitamin D deficiency, might be a common mechanism controlling the expressivity of most autism predisposition genes and even core symptoms of autism.”

Headline

https://www.mdpi.com/1422-0067/20/24/6332/pdf